Cargando…
IFNG, FCER1A, PCDHB10 expression as a new potential marker of efficacy in grass pollen allergen-specific immunotherapy
INTRODUCTION: Allergen-specific immunotherapy (AIT) is the core treatment in allergic rhinitis and asthma. Although widely used, some patients do not benefit from treatment and there is no efficacy objective marker. AIM: To define the profile of gene transcripts during the build-up phase of AIT and...
Autores principales: | Romantowski, Jan, Maciejewska, Agnieszka, Polanska, Joanna, Wasilewska, Eliza, Specjalski, Krzysztof, Chełminska, Marta, Jassem, Ewa, Niedoszytko, Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501422/ https://www.ncbi.nlm.nih.gov/pubmed/34658711 http://dx.doi.org/10.5114/ada.2021.108925 |
Ejemplares similares
-
Smoking history is negatively associated with allergen specific immunotherapy efficacy: a retrospective analysis
por: Romantowski, Jan, et al.
Publicado: (2019) -
YKL-40 Protein Correlates with the Phenotype of Asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015) -
YKL-40 as a possible marker of neutrophilic asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2023) -
Efficiacy of injection specific immunotherapy for grass pollen seasonal allergic rhinitis
por: Wasilewska, Eliza, et al.
Publicado: (2015) -
The prevalence of Api m 10 sensitization and the modification of immunotherapy in bee venom allergy
por: Górska, Aleksandra, et al.
Publicado: (2021)